glp 1 and covid 19 Could GLP-1 medications help slow cancer progression? A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to GLP-1 Agonists in Cardiovascular Diseases:
Description
And the exercise interaction backs this up: higher fitness builds a greater parasympathetic reserve (essentially, a better ability to slow your heart rate), which helps offset the sympathetic drive from GLP-1
Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population
Sitagliptin is the first of a class of drugs to be approved that mimics the actions of the dipeptidyl peptidase-4 (DPP-4) enzyme.
Learn about high-quality research peptides and stay updated with Nationwide Peptides
